PatentPeptide und Kombinationen von Peptiden zur Verwendung in der Immuntherapie gegen eine Infektion durch SARS-COV-2…

Basic data

Title:
Peptide und Kombinationen von Peptiden zur Verwendung in der Immuntherapie gegen eine Infektion durch SARS-COV-2 (COVID-19)
Reference number (DPMA):
60 2021 018 014.4
Primary registration:
29/07/2021

Inventors

Bilich, Tatjana
formerly Universität Tübingen
Faculty of Medicine
University of Tübingen
Department of Biology
Faculty of Science
Cluster of Excellence: Image-Guided and Functionally Instructed Tumor Therapies (iFIT)
Centers or interfaculty scientific institutions
Institut for Immunology
Non-clinical institutes, Faculty of Medicine
Faculty of Medicine
University of Tübingen
Institut for Immunology
Non-clinical institutes, Faculty of Medicine
Help

will be deleted permanently. This cannot be undone.